宇華教育(06169.HK)因轉換可換股貸款向國際金融公司發行3512萬股
格隆匯2月4日丨宇華教育(06169.HK)公佈,2020年1月30日,公司收到國際金融公司的轉換通知,按換股價每股5.53港元轉換貸款的可換股貸款2490萬美元的本金總額。上述轉換後,該公司合共3512萬股股份將發行予國際金融公司。
國際金融公司是世界銀行的姊妹機構兼世界銀行集團的成員公司。國際金融公司通過為私營公司投資提供資金、調動國際金融市場中的資本以及向企業與政府提供顧問服務,促進發展中國家經濟的可持續增長。自1985年以來,國際金融公司已為中國超過200個項目提供資金,以支持多個行業(包括健康與教育、服務、農業、製造、銀行與金融市場、基礎設施及私募股權基金)私營公司的可持續發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.